Keywords: Moscow; Russia; Angiology; Antihyperlipidemic Agents; Atorvastatin Therapy; Cardiology; Cardiovascular; Cardiovascular Diseases and Conditions; Cardiovascular Research; Clinical Research; Clinical Trials and Studies; Health and Medicine; Lipid Research; Lipids; Lipoproteins; Risk and Prevention EN Moscow Russia Angiology Antihyperlipidemic Agents Atorvastatin Therapy Cardiology Cardiovascular Cardiovascular Diseases and Conditions Cardiovascular Research Clinical Research Clinical Trials and Studies Health and Medicine Lipid Research Lipids Lipoproteins Risk and Prevention 581 581 1 09/19/23 20230918 NES 230918 2023 SEP 18 (NewsRx) -- By a News Reporter-Staff News Editor at Clinical Trials Week -- Current study results on Cardiovascular Diseases and Conditions have been published. This treatment allows reducing atherogenic low-density lipoprotein cholesterol (LDL-C) by approximately 50 % and decreasing the risk of cardiovascular diseases." Moscow, Russia, Angiology, Antihyperlipidemic Agents, Atorvastatin Therapy, Cardiology, Cardiovascular, Cardiovascular Diseases and Conditions, Cardiovascular Research, Clinical Research, Clinical Trials and Studies, Health and Medicine, Lipid Research, Lipids, Lipoproteins, Risk and Prevention. [Extracted from the article]